News
News
24
April
2025
Primo’s Taoyuan Facility Achieves PIC/S GMP Certification, Paving the Way for Global Expansion in Nuclear Medicine.
19
March
2025
Primo Partners with ABX to Bring PB01 Closer to Taiwan’s Prostate Cancer Market
13
January
2025
Primo Partners with SHINE to Advance Precision Cancer Care in Asia-Pacific
9
January
2025
Primo Biotechnology Partners with Antelope Surgical Solutions for World’s First FDA-Approved Phase I/II Trial of AS1986NS
17
November
2023
Primo wins 2023 TAIPEI Prominent Enterprise Award
21
July
2023
Primo Biotechnology Raises Over 6.5 Million USD in Funding, Pioneering an International-level Radiopharmaceutical Manufacturing Facility
1
July
2022
Dr. Chi-Wei Chang joins Primo as CTO of Radiopharmaceutical Chemistry.
1
May
2022
Tackle Cancer Challenge
18
NOV
2021
Are Asian Countries Ready for Novel Radiopharmaceuticals?
15
NOV
2021